Annual Drug Patent Expirations for EMPAVELI
Empaveli is a drug marketed by Apellis Pharms and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.
This drug has one hundred and twenty-one patent family members in twenty-four countries.
The generic ingredient in EMPAVELI is pegcetacoplan. One supplier is listed for this compound. Additional details are available on the pegcetacoplan profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
